The Center applies a multidisciplinary approach to the treatment of digestive tract tumors, including cooperation with other hospital departments.

Discussions and decisions take place in a framework bringing together oncologists, surgeons, and radiology, nuclear medicine, and pathology specialists.

Through the discussions the team develops a therapeutic strategy for each patient: Combinations of chemotherapy and biological treatment; removal of metastases; the burning of metastases (radio frequency); direct chemotherapy to the liver; warming of the abdominal cavity, etc. 

Active research

1. Metastatic colonic cancer in the liver only; operable metastases; pre-op therapy combining avastin, chemotherapy, and arbitox.

2. Metastatic colonic cancer – first line of treatment; treatment with oxaliplatin and infusion of 5FU and arbitox compared to oxaliplatin, UFT tablets, and arbitox.

3. Second line treatment for metastatic GIST where treatment with Gleevec has failed.